Page 23 - รายงานประจำปี ๒๕๕๘ ศูนย์องค์รวมเพื่อการศึกษาและบำบัดโรคมะเร็ง คณะแพทยศาสตร์

23

Clinical Studies

1. Advanced Stage Lung Cancer

1.1 Maintenance vaccine, stage IIIA-IV NSCLC : RACO
1.2 First line, , stage IIIB-IV NSCLC : FLAURA 1
1.3 First line, EGFR vaccine, stage IV NSCLC: BV-NSCLC-002

2. First line, Metastatic Gastric Cancer
2.1 HER2 +ve: JACOB

3. Prevention of Chemotherapy-Induced Nausea and Vomiting

3.1 Highly emetogenic chemotherapy: NETU-12-07

4. Advanced Solid Tumors : SBG

5. Second line, Recurrent/Metastatic head and neck squamous cell carcinoma
5.1 CBKM120H2201

5.2 BI 1200.161

6. Second line Esophageal cancer
6.1 ESCC_BKM120

7. Locally Advanced or Metastatic Breast Cancer

7.1 First line, HER2 +ve: MYLAN

8. Stage IIIC-IV, Acral Lentiginous or cutaneous melanoma
8.1 Acral Lentiginous or cutaneous